Source: International Congress 2017 – Bronchial asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Tagaya (Tokyo, Japan). Effect of optimized anti-inflammatory treatment in patients with asthma and eosinophilic otitis media. 658

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic otitis media and eosinophilic asthma; shared pathophysiology and response to anti-IL5 Source: International Congress 2018 – CC7 Severe asthma Year: 2018 Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Long-term treatment with low-dose azithromycin reduces cough, sputum production and exacerbations in patients with idiopathic diffuse bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Severe asthma exacerbations with eosinophilic bronchitis: a randomized controlled comparison of the anti-inflammatory effects of deflazacort vs. prednisone Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006 Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Induced sputum in children with intermitent and persistent asthma: the effect to treatment Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 553s Year: 2007 Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Effect of azithromycin treatment on inflammation in COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Different treatment courses with inhaled corticosteroids for eosinophilic bronchitis Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD Source: Eur Respir J 2007; 30: Suppl. 51, 141s Year: 2007 Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008